Related Experiment Video
Updated: Feb 16, 2026

Models of Bone Metastasis
Published on: September 4, 2012
Runx2 overexpression compromises bone quality in acromegalic patients
Maria Teresa Valenti1, Monica Mottes2, Samuele Cheri1,3
1Department of MedicineInternal Medicine, Section D, University of Verona, Verona, Italy.
Abstract:
Acromegalic patients, characterized by excessive secretion of GH and IGF-1, show a high fracture risk but bone mineral density is a poor predictor for bone fractures in these patients. The effects of an excess of GH/IGF1 on skeleton as well as on osteogenic progenitors, i.e. mesenchymal stem cells, have not been investigated in these patients. We aimed to elucidate the skeletal conditions of acromegalic patients by means of bone microarchitecture analysis and evaluation of MSCs osteogenic commitment. In particular, we performed histomorphometric analyses, and we quantified the expression levels of the osteogenic transcription factor RUNX2 in circulating MSCs. Our results showed an abnormal microarchitecture and demonstrated that bone impairment in acromegalic patients is associated with the upregulation of RUNX2 expression. Furthermore, osteoblastic activity was significantly reduced in patients under pharmacological treatment, compared to untreated patients. In conclusion, this study demonstrates the key role of RUNX2 gene overexpression in causing bone impairment in acromegalic patients. It also suggests a therapeutic approach for the improvement of bone quality, focused on the osteoblastic lineage rather than the inhibition of osteoclastic activity.
Insights
Acromegaly patients exhibit poor bone quality due to abnormal RUNX2 gene expression. Targeting osteoblastic lineage may improve bone health in these individuals.
Area of Science:
- Endocrinology
- Bone Biology
- Stem Cell Research
Background:
- Acromegaly, caused by excess growth hormone (GH) and insulin-like growth factor 1 (IGF-1), leads to high fracture risk.
- Bone mineral density is an unreliable predictor of fractures in acromegalic patients.
- The impact of GH/IGF-1 excess on bone microarchitecture and mesenchymal stem cells (MSCs) is not well understood.
Purpose of the Study:
- To investigate skeletal conditions in acromegaly by analyzing bone microarchitecture.
- To evaluate the osteogenic commitment of MSCs in acromegalic patients.
- To determine the role of RUNX2 expression in bone impairment.
Main Methods:
- Histomorphometric analysis of bone microarchitecture.
- Quantification of osteogenic transcription factor RUNX2 expression in circulating MSCs.
- Comparison of osteoblastic activity between treated and untreated patients.
Main Results:
- Acromegalic patients display abnormal bone microarchitecture.
- Bone impairment is linked to increased RUNX2 expression in MSCs.
- Osteoblastic activity is reduced in patients receiving pharmacological treatment.
Conclusions:
- Overexpression of RUNX2 is a key factor in bone impairment in acromegaly.
- Therapeutic strategies should focus on enhancing osteoblastic lineage for bone quality improvement.
- Inhibition of osteoclastic activity may not be the optimal approach for treating bone issues in acromegaly.
More Related Videos
Related Concept Videos
Quality Control
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
Quality Assurance
Quality of Water
Pulse amplitude and quality
A weak or absent pulse may indicate reduced cardiac output or poor left ventricular contraction, which can be signs of cardiovascular dysfunction or...
Testing Water Quality
Bone Structure

